Michael Brent Tignor - 12 Feb 2025 Form 4/A - Amendment Insider Report for BALCHEM CORP (BCPC)

Role
SVP & Chief HR Officer
Signature
/s/ Travis Larsen, Attorney in Fact for Michael Brent Tignor
Issuer symbol
BCPC
Transactions as of
12 Feb 2025
Net transactions value
-$188,590
Form type
4/A - Amendment
Filing time
11 Apr 2025, 18:43:35 UTC
Date Of Original Report
14 Feb 2025
Previous filing
12 Feb 2025
Next filing
10 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +1,290 +19% $0.000000 8,072 12 Feb 2025 Direct F1
transaction BCPC Common Stock Award $0 +2,207 +27% $0.000000 10,279 13 Feb 2025 Direct F2
transaction BCPC Common Stock Tax liability $188,590 -1,156 -11% $163.14 9,123 13 Feb 2025 Direct F3
holding BCPC Common Stock 1,307 12 Feb 2025 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +4,200 $0.000000 4,200 12 Feb 2025 Common Stock 4,200 $159.18 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person ratably over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Represents the vesting of performance stock units (includes 36 dividend equivalent shares) for the 2022-2024 performance period.
F3 1,156 of the 2,207 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.
F4 Options vest 20% Year 1; 40% Year 2; and 40% Year 3.

Remarks:

This Form 4/A amends and restates the original Form 4 filed on February 14, 2025, which inadvertently noted the vesting period for restricted stock as 3 years from the grant date, instead of a ratable vesting over a 3-year period.